# ALYMSYS

NDC: 85006-1755
Generic name: bevacizumab-maly
Labeler / Manufacturer: Valorum Biologics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260330

FDA application: BLA761231

## Active ingredients

- BEVACIZUMAB-MALY: 400 mg/16mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85006-1755"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85006-1755
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42b4f96e-1f70-2126-e063-6294a90a93e3
